Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Deferiprone

EU orphan designation number: EU/3/10/832   
Active ingredient: Deferiprone
Indication: Treatment of sickle cell disease
Sponsor: Apotex Europe B.V.
Darwinweg 20, 2333 CR Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/03/2011 Orphan designation EMA/OD/077/10 (2011)1298 of 23/02/2011